XOMA Royalty Corp.
NASDAQ:XOMABiotechnology
Healthcare
$40.17 +0.44%
+$0.19 today
- Market cap
- $503.77M
- Beta
- 0.87
- P/E (TTM)
- 15.8
- EPS (TTM)
- $2.65
52W Low $22.29High $42.81
Volume 4.22M
Average 0.21M
Income Statement
Follow revenue through to earnings.
Revenue
$52.15M
FY 2025 · Annual
+83.1% YoYOperating Income
$11.38M
FY 2025 · Annual
Net Income
$31.71M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 38.16M | 6.03M | 4.76M | 28.49M | 52.15M |
| Cost of Revenue | 171K | 274K | 143K | 206K | 2.96M |
| Gross Profit | 37.99M | 5.75M | 4.62M | 28.28M | 49.18M |
| Gross Margin | 99.6% | 95.5% | 97.0% | 99.3% | 94.3% |
| Research & Development | 171K | 153K | 143K | 2.88M | 1.71M |
| Selling, General & Admin | 20.46M | 23.19M | 27.18M | 34.48M | 36.09M |
| Operating Expenses | 20.46M | 23.17M | 46.46M | 68.26M | 37.79M |
| Depreciation & Amortization | 167K | 274K | 900K | 216K | 2.97M |
| EBITDA | 16.52M | (16.85M) | (22.56M) | (5.42M) | 47.82M |
| EBITDA Margin | 43.3% | -279.5% | -474.2% | -19.0% | 91.7% |
| Operating Income | 17.53M | (17.41M) | (41.85M) | (39.98M) | 11.38M |
| Operating Margin | 45.9% | -288.9% | -879.5% | -140.3% | 21.8% |
| Interest Income | 0 | 694K | 0 | 0 | 0 |
| Interest Expense | 461K | 0 | 569K | 13.84M | 13.03M |
| Other Income / Expenses | (1.64M) | 295K | 1.02M | 20.5M | 20.43M |
| Income Before Tax | 15.89M | (17.12M) | (40.83M) | (19.48M) | 31.82M |
| Pre-Tax Margin | 41.6% | -284.0% | -858.2% | -68.4% | 61.0% |
| Income Tax Expense | 91K | (15K) | 0 | (5.66M) | 103K |
| Net Income | 15.8M | (17.1M) | (40.83M) | (13.82M) | 31.71M |
| Net Margin | 41.4% | -283.8% | -858.2% | -48.5% | 60.8% |
| EPS (Basic) | 0.69 | (1.98) | (4.04) | (1.65) | 1.53 |
| EPS (Diluted) | 0.65 | (1.98) | (4.04) | (1.65) | 1.46 |
| 11.29M | 11.41M | 11.47M | 11.7M | 17.98M | |
| 12.19M | 11.41M | 11.47M | 11.7M | 17.98M |
XOMA Earnings Waterfall · TTM
NASDAQ:XOMA · Revenue to Net Income
Key Ratios
EPS$1.57
Gross Margin94.6%
Net Margin166.3%
P/E Ratio15.0
P/S Ratio109.8
Analysis
$36.2M of revenue converted into $31.5M of net income for the selected period. Gross margin is 94.6% and net margin is 166.3%, showing how much revenue survives after costs and taxes. EPS is $1.57, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| DEFA14A | DEFA14A filing | Jun 12, 2026 | |
| 8-K | Current report | Jun 12, 2026 | |
| DEFM14A | DEFM14A filing | Jun 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 26, 2026 | |
| 4 | Statement of changes in beneficial ownership | May 26, 2026 |
How much revenue does XOMA generate?
XOMA Royalty Corp. (XOMA) reported $52.15M of revenue in fiscal 2025.
Is XOMA profitable?
XOMA Royalty Corp. (XOMA) reported $31.71M of net income, with a net margin of 60.8%.
Continue the stock analysis
Jump to another research area for this company.